CARGO Therapeutics Inc. (CRGX) Accounting Value per Share

Official company branding of CARGO Therapeutics, Inc. (CRGX)

Flawless bioreactor calibration ensures high component quality, and the GURU.Markets terminal displays the book value chart for the common share of CARGO Therapeutics (CRGX), where the latest parameter is 5.08. This price action confirms the expansion of CAR-T therapy for combating lymphomas. High barriers to entry and patent protection for cell modification methods render this market inaccessible to new players.

CRGX Cargo Therapeutics Net Asset Value per Share (02/21/2024 - 08/30/2025)

CRGX (cargo-tx.com): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Cargo Therapeutics|CRGX - Analyst Target Range
- market capitalization details:
Market Valuation CARGO Therapeutics, Inc.|CRGX - Business Value
- balance sheet net asset value indicators:
Net Assets per Single Share CARGO Therapeutics|CRGX - Total Stockholders' Equity|Market Value to Book Value Ratio cargo-tx.com|CRGX - Total Business Assets
- debt burden and liquidity indicators:
Total Debt to Capital CARGO Therapeutics|CRGX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity CARGO Therapeutics, Inc.|CRGX - Company Cumulative Debt|Debt to Book Capitalization Ratio CARGO Therapeutics, Inc.|CRGX - Company Long-Term Debt|Company Short-Term Debt CARGO Therapeutics|Quick Ratio cargo-tx.com
- earnings and multiples data:
CRGX - Annual Net Income
Basic company analysis:CRGX - Cargo Therapeutics
Manufactured products of CARGO Therapeutics, Inc.

Book value per share reflects the issuer's net assets divided by the number of securities, determining the liquidation value of a single share. Analyzing the historical book value per share allows for an assessment of capital preservation at CARGO Therapeutics (CRGX), which is critical when financing costly cancer cell therapy developments in collaboration with academic laboratories.

Competitor analysis for CARGO Therapeutics

Legend Biotech Inc. - Book Value per Share|Book Value of One Share Sana Corp (SANA)|AUTL (Autolus Therapeutics) - Accounting Value per Share|Equity per Share ALLO|Net Assets per Single Share Cartesian Therapeutics, Inc.|Net Asset Value per Share Cellectis Biotherapeutics CLLS|Net Assets per Single Share Caribou Bio (CRBU)|Instil Bio Inc - Equity per Share|Book Value per Share GNTA (Genenta Science)|IPSC - Accounting Value per Share|JSPR - Net Assets per Single Share|Net Asset Value per Share Senti Biosciences, Inc.|adaptimmune.com (ADAP) - Net Assets per Single Share|CERO (CERo Therapeutics Holdings) - Net Assets per Single Share|Net Assets per Single Share Alaunos Therapeutics Inc.|Net Asset Value per Share Achilles Tx ACHL|Book Value per Share PSTX|2seventy bio Inc. (TSVT) - Book Value of One Share|Gracell Biotechnologies Ltd - Accounting Value per Share